Kevin Jon Williams

Has grant

Professor of Cardiovascular Sciences; Professor of Medicine

Lewis Katz School of Medicine at Temple University

United States

Research Interests

Explore related searches

Professors in United States

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Kevin Jon Williams is a Professor of Cardiovascular Sciences and Professor of Medicine at the Lewis Katz School of Medicine at Temple University. His research areas include the management of atherosclerotic cardiovascular events in patients with conditions such as dermatomyositis and lupus erythematosus, as well as genomic analyses in cancer. Recent publications reflect his commitment to advancing therapeutic strategies for cardiovascular health and addressing the complexities of systemic diseases.

Recent Grants

Grant: Close

Residual cardiovascular risk: novel pathways and potential target discovery

Open Date: 2014-01-01

Close Date: 2016-12-01

Grant: Close

Sulfatase-2: Key mediator of atherogenic postprandial dyslipoproteinemia

Open Date: 2013-09-20

Close Date: 2018-06-30

Grant: Close

NOX4 dysfunction as the basis for both fatty liver and poor glucose handling in type 2 diabetes

Open Date: 2013-01-01

Close Date: 2015-12-01

Grant: Close

Endocytic Trafficking Motifs in Syndecan &LDL receptor

Open Date: 2005-05-01

Close Date: 2010-04-30

Articles (16)

Year:

2025

Year:

2025

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Year:

2021

Year:

2021

Collaborators (2)

Cherie Lisa Vaz

Temple University School of Medicine

UNITED STATES

View details

Victoria P. Werth

UNITED STATES

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Kevin Jon Williams

Research Interests

Explore related searches

Contact this professor

About

Recent Grants

Articles (16)

Divergence in Estimated Risks and Actual Rates of Atherosclerotic Cardiovascular Events and their Management in a Longitudinal Cohort of Patients with Dermatomyositis with Skin Involvement

Modern therapy of patients with lupus erythematosus must include appropriate management of their heightened rates of atherosclerotic cardiovascular events: a literature update

The value of a negative study

Eradicating Atherosclerotic Events by Targeting Early Subclinical Disease: It Is Time to Retire the Therapeutic Paradigm of Too Much, Too Late

Pan-cancer Genomic Analysis of AXL Mutations Reveals a Novel, Recurrent, Functionally Activating AXL W451C Alteration Specific to Myxofibrosarcoma.

Time in range in patients with type 2 diabetes who are long‐term users of d‐Nav®, an artificial intelligence‐driven technology for autonomous titration of insulin dosing

State of current management of the heightened risk for atherosclerotic cardiovascular events in an established cohort of patients with lupus erythematosus

Arterial Zones That Take a Pause in Early Plaque Development

Back Cover

Challenging the 50‐50 rule for the basal‐bolus insulin ratio in patients with type 2 diabetes who maintain stable glycaemic control

Challenging the 50-50 rule for the basal-bolus insulin ratio in patients with type 2 diabetes who maintain stable glycaemic control

THE STATE OF CURRENT MANAGEMENT OF THE HEIGHTENED RISK FOR ATHEROSCLEROTIC CARDIOVASCULAR EVENTS IN AN ESTABLISHED COHORT OF PATIENTS WITH LUPUS ERYTHEMATOSUS

Pelvic floor symptoms among premenopausal women with pelvic organ prolapse in the Democratic Republic of the Congo.

HPV51-associated Leiomyosarcoma A Novel Class of TP53/RB1-Wildtype Tumor With Predilection for the Female Lower Reproductive Tract

A randomized controlled trial of an innovative, user‐friendly, interactive smartphone app‐based lifestyle intervention for weight loss

A randomized controlled trial of an innovative, user-friendly, interactive smartphone app-based lifestyle intervention for weight loss

Collaborators (2)

Cherie Lisa Vaz

Victoria P. Werth

Make your next move.